when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

OVERSEAS · news · pharmadog

← back to OVERSEAS

News mentioning OVERSEAS

42 stories

2hFDA launches pilot program to speed up early US drug researchbiopharma dive

4dSamsung Biologics inks $262M manufacturing deal with European pharma companybiospace

4dIn first interview as FDA oncology chief, Angelo de Claro vows to ‘continue the innovation’ behind OCE legacyfiercebiotech

4dSingapore launches biotech-focused Boston hub to build on 'centuries-old bond'fiercebiotech

6dBeyond China: Five other overseas destinations for biopharma dollarsbiospace

12dFDA leaders project enhanced scrutiny of foreign dataendpoints

13dSTAT+: The Ig Nobel Prizes, long held in the U.S., head to Europe due to Trump policiesstat

20dAmgen, academic centers weigh new FDA pilot to speed early drug trialsendpoints

21dOmicsBank raises $2.25M to bring overseas patient data to biopharmaendpoints

21dLilly takes oral obesity race abroad with UK launch of Foundayobiospace

27dWith China rising, Hong Kong builds bridge to biotech innovationbiospace

27dNovo takes first round of oral obesity duel. Can it stay ahead of Lilly?biospace

28dRebounding biotech funds expected to spur CDMO growth within yearbiospace

28dOpinion: 8 steps to making surrogacy more ethical for everyone involvedstat

29d‘Money has spoken’: Why Chinese biotech CEOs tell Fierce they’re unfazed about rising US tensionsfiercebiotech

Aug 14, 26After 2 undisclosed gene therapy deaths, can China’s alternative regulatory path still be trusted?fiercebiotech

Aug 14, 26Nascent US psychedelic therapy opportunity attracts overseas manufacturersbiospace

Aug 10, 26AstraZeneca partners with CSPC to build Chinese biologics manufacturing plantbiospace

Aug 10, 26FDA warns firm in India for falsified logbooks; two other companies warned for lax testingraps

Aug 3, 26Biotech leaders call for streamlining of INDs as FDA’s Trialblazer rolls outbiospace

Jul 31, 26Syphilis spreads while researchers contend with federal constraints and a drug shortagestat

Jul 16, 26‘Substantially better than before’: Why India has golden opportunity to build on innovative R&D winsfiercebiotech

Jul 15, 26STAT+: Bipartisan lawmakers want to require U.S. to probe reliance on foreign-made drugs, ingredientsstat

Jul 9, 26HHS plan to speed drug research won’t remove ‘self-inflicted’ delaysbiopharma dive

Jul 8, 26STAT+: In private meeting, Trump officials push to onshore generic drugmakingstat

Jun 29, 26FDA Selects Seven Participants for PreCheck Pilot Program to Advance U.S. Drug Manufacturingfda press

Jun 9, 26A leader of the 2014 U.S. Ebola response compares then to nowstat

Jun 8, 26Opinion: American horses are obese, toostat

Jun 6, 26Opinion: How the Amish think about vaccines, health care costs, and much morestat

Jun 6, 26Opinion: I led the U.S. CDC response to the 2014 Ebola epidemic. The new outbreak needs massive, immediate, meticulous actionstat

← prevpage 1 of 2next →